{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:46:02Z","timestamp":1761896762135},"reference-count":84,"publisher":"Informa UK Limited","issue":"9","funder":[{"name":"Bristol-Myers Squibb s.r.l"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.2217\/imt-2018-0014","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T13:39:54Z","timestamp":1525786794000},"page":"807-821","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":13,"title":["Abatacept in the Treatment of Psoriatic Arthritis: Biological and Clinical Profiles of the Responders"],"prefix":"10.1080","volume":"10","author":[{"given":"Gaetano","family":"Zizzo","sequence":"first","affiliation":[{"name":">Institute of Rheumatology & Affine Sciences,Fondazione Policlinico Universitario Agostino Gemelli - Catholic University of the Sacred Heart, via Giuseppe Moscati 31, Rome00168, Italy"},{"name":"Rheumatology Clinic, Medical Department, ASST Monza, via Giuseppe Mazzini 1, Desio20832, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Gremese","sequence":"additional","affiliation":[{"name":">Institute of Rheumatology & Affine Sciences,Fondazione Policlinico Universitario Agostino Gemelli - Catholic University of the Sacred Heart, via Giuseppe Moscati 31, Rome00168, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianfranco","family":"Ferraccioli","sequence":"additional","affiliation":[{"name":">Institute of Rheumatology & Affine Sciences,Fondazione Policlinico Universitario Agostino Gemelli - Catholic University of the Sacred Heart, via Giuseppe Moscati 31, Rome00168, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,5,8]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.9592.1"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000152"},{"issue":"8","key":"e_1_3_2_5_1","first-page":"1251","article-title":"New GRAPPA and EULAR recommendations for the management of psoriatic arthritis","volume":"56","author":"Coates LC","year":"2017","unstructured":"Coates LC , GossecL , RamiroSet al. New GRAPPA and EULAR recommendations for the management of psoriatic arthritis . Rheumatology (Oxford)56 ( 8 ), 1251 \u2013 1253 ( 2017 ).","journal-title":"Rheumatology (Oxford)"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes001"},{"key":"e_1_3_2_7_1","first-page":"7692024","article-title":"T helper cell subsets in clinical manifestations of psoriasis","author":"Diani M","year":"2016","unstructured":"Diani M , AltomareG , RealiE . T helper cell subsets in clinical manifestations of psoriasis . J. Immunol. Res.2016 , 7692024 ( 2016 ).","journal-title":"J. Immunol. Res."},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar4414"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19010179"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2015.07.010"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.09.015"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.5.681"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.050963"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1987.tb05869.x"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6621"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.04.020"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000000239"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501810"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar3817"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar1864"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.154.6.2668"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2017.11.007"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13027"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122198"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2010.10.002"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2008.194"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-2961-7"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.399"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar4317"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38995"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200939687"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.7.4733"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.261"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.477"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1600364"},{"issue":"60","key":"e_1_3_2_36_1","first-page":"413","article-title":"The potential role of Th17 in mediating the transition from acute to chronic autoimmune inflammation: rheumatoid arthritis as a model","volume":"11","author":"Ferraccioli G","year":"2011","unstructured":"Ferraccioli G , ZizzoG . The potential role of Th17 in mediating the transition from acute to chronic autoimmune inflammation: rheumatoid arthritis as a model . Discov. Med.11 ( 60 ), 413 \u2013 424 ( 2011 ).","journal-title":"Discov. Med."},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005087"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12938"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-1196-6"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2017.04.001"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21749"},{"issue":"22","key":"e_1_3_2_42_1","first-page":"5166","article-title":"Peripheral blood CD8+ T-cell profiles in patients with psoriatic arthritis: a cross-sectional case-control study","volume":"21","author":"Colombo E","year":"2017","unstructured":"Colombo E , GalleriG , ErreGLet al. Peripheral blood CD8+ T-cell profiles in patients with psoriatic arthritis: a cross-sectional case-control study . Eur. Rev. Med. Pharmacol. Sci.21 ( 22 ), 5166 \u2013 5171 ( 2017 ).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.113233"},{"issue":"8","key":"e_1_3_2_44_1","first-page":"1519","article-title":"Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study","volume":"70","author":"Buch MH","year":"2009","unstructured":"Buch MH , BoyleDL , RosengrenSet al. Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study . Ann. Rheum. Dis.70 ( 8 ), 1519 ( 2009 ).","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"e_1_3_2_45_1","first-page":"204","article-title":"Reduction of peripheral blood T cells producing IFN-\u03b3 and IL-17 after therapy with abatacept for rheumatoid arthritis","volume":"32","author":"Scarsi M","year":"2014","unstructured":"Scarsi M , ZanottiC , ChiariniMet al. Reduction of peripheral blood T cells producing IFN-\u03b3 and IL-17 after therapy with abatacept for rheumatoid arthritis . Clin. Exp. Rheumatol.32 ( 2 ), 204 \u2013 210 ( 2014 ).","journal-title":"Clin. Exp. Rheumatol."},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.30176"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210724"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38376"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204782"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2865"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.080713"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.085084"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-011-9527-5"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1364-3"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00480"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1001311"},{"key":"e_1_3_2_57_1","first-page":"7346030","article-title":"Activated circulating T follicular helper cells are associated with disease severity in patients with Psoriasis","author":"Wang Y","year":"2016","unstructured":"Wang Y , WangL , YangH , YuanW , RenJ , BaiY . Activated circulating T follicular helper cells are associated with disease severity in patients with Psoriasis . J. Immunol. Res.2016 , 7346030 ( 2016 ).","journal-title":"J. Immunol. Res."},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402260"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115424"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI5857"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex012"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40165"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20160258"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.145946"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2011.02.018"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.097030"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160532"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500306"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00576"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.01.010"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2016.11.105"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12001"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1038\/nutd.2012.26"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker349"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201299"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-1194-8"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-017-3788-1"},{"issue":"10","key":"e_1_3_2_78_1","article-title":"Body mass index does not influence the efficacy of subcutaneous abatacept in patients with PsA: results from a Phase III Trial","volume":"69","author":"McInnes IB","year":"2017","unstructured":"McInnes IB , FerraccioliG , D'AgostinoMet al. Body mass index does not influence the efficacy of subcutaneous abatacept in patients with PsA: results from a Phase III Trial . Arthritis Rheumatol.69 ( Suppl. 10 ), Abstract 609 ( 2017 ).","journal-title":"Arthritis Rheumatol."},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2017.1329009"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.37876"},{"key":"e_1_3_2_81_1","first-page":"S1132","article-title":"Traitement de la spondylarthrite (SpA) axiale r\u00e9fractaire aux anti-TNFalpha par CTLA-4-Ig (abatacept), r\u00e9sultats d'une \u00e9tude ouverte pilote [abstract]","volume":"76","author":"Compaor\u00e9 C","year":"2009","unstructured":"Compaor\u00e9 C , d'AgostinoMA , BelmiloudS , Le ParcJM , BrebanM . Traitement de la spondylarthrite (SpA) axiale r\u00e9fractaire aux anti-TNFalpha par CTLA-4-Ig (abatacept), r\u00e9sultats d'une \u00e9tude ouverte pilote [abstract] . Rev. Rhum.76 , S1132 ( 2009 ).","journal-title":"Rev. Rhum."},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-009-1041-1"},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.4103\/0976-500X.120943"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2011.01405.x"},{"key":"e_1_3_2_85_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150744"},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-017-3919-7"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt-2018-0014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T16:08:24Z","timestamp":1715962104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt-2018-0014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,8]]},"references-count":84,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["10.2217\/imt-2018-0014"],"URL":"https:\/\/doi.org\/10.2217\/imt-2018-0014","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-01-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}